<http://schema.org/description>
"Shares of biotech company Amarin , already down more than 70% in the last month, fell another 13% after it announced that the FDA has rescinded its SPA (Special Protocol Assessment) for Vascepa."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/10/30/down-13-more-bad-luck-for-amarin-corporation-plc/20757774/>